Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Mar 22, 2023

BUY
$7.82 - $12.44 $6,256 - $9,952
800 New
800 $6.26 Million
Q1 2021

Mar 22, 2023

BUY
$9.33 - $14.05 $25,657 - $38,637
2,750 New
2,750 $34.7 Million
Q4 2020

Mar 22, 2023

BUY
$8.48 - $12.23 $23,320 - $33,632
2,750 New
2,750 $25.8 Million
Q3 2020

Mar 22, 2023

BUY
$9.99 - $14.41 $38,551 - $55,608
3,859 New
3,859 $42.1 Million
Q2 2020

Mar 24, 2023

SELL
$12.28 - $17.63 $3,684 - $5,289
-300 Closed
0 $0
Q1 2020

Mar 24, 2023

BUY
$11.31 - $18.26 $3,393 - $5,478
300 New
300 $3.99 Million
Q4 2019

Mar 24, 2023

BUY
$6.44 - $14.21 $1,932 - $4,263
300 New
300 $4.2 Million
Q3 2019

Mar 24, 2023

BUY
$4.6 - $8.46 $3,679 - $6,768
800 Added 48.48%
2,450 $16.1 Million
Q2 2019

Mar 24, 2023

BUY
$5.83 - $8.42 $9,619 - $13,893
1,650 New
1,650 $13.8 Million
Q1 2019

Mar 24, 2023

BUY
$4.02 - $5.81 $4,019 - $5,810
1,000 New
1,000 $5.81 Million

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $10.1M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.